| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
KINGSWAY Corp
13D/A
Amendment 2
KWY · 496904202
|
10.3% |
5/20/2026
Event 5/18/2026
|
|||
| David Capital Partners, LLC | 9.0% | ||||
| David Capital Partners Fund, LP | 3.5% | ||||
| David Capital Partners Special Situation Fund, LP | 5.5% | ||||
| Adam J. Patinkin | 10.3% | ||||
|
Kingsway Financial Services Inc.
13D/A
Amendment 1
KWY · 496904202
|
9.0% |
12/18/2025
Event 12/17/2025
|
|||
| David Capital Partners, LLC | 9.0% | ||||
| David Capital Partners Fund, LP | 3.5% | ||||
| David Capital Partners Special Situation Fund, LP | 5.5% | ||||
| Adam J. Patinkin | 9.0% | ||||
|
Kingsway Financial Services Inc.
13D
KWY · 496904202
|
9.2% |
4/2/2025
Event 3/26/2025
|
|||
| David Capital Partners, LLC | 9.2% | ||||
| David Capital Partners Fund, LP | 3.7% | ||||
| David Capital Partners Special Situation Fund, LP | 5.5% | ||||
| Adam J. Patinkin | 9.2% | ||||
|
Lifecore Biomedical, Inc. \De\
13G/A
Amendment 1
LFCR · 514766104
|
4.9% |
2/5/2025
Event 12/31/2024
|
|||
| David Capital Partners, LLC | 4.9% | ||||
| David Capital Partners Fund, LP | 4.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.